Prophylactic effect of Elental on stomatitis in chemotherapy with or without radiation for esophageal cancer
- Conditions
- Esophagealcancer
- Registration Number
- JPRN-UMIN000011956
- Lead Sponsor
- Department of Gastroenterology, Toranomon Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 84
Not provided
1. patients withe the past history of allergy to iodine 2. patients without cessation of anticoagulant therapy 3. Presence of other cancer 4. Pregnant or nursing women and those with the possibility of pregnancy 5. Mental or neurologic disease that might affect participation 6. Receiving steroid therapy 7. Positive HBs Antigen 8. Active infection 9. Presence of recent MI or history of unstable AP 10. Presence of uncorolled diabetes 11. Presence of uncontrolled hypertention 12. Presence of IP, pulmonary fibrosis, or severe CPE 13. patients with the past history of hypersensitivity to Elental 14. Abnormality in amino acid metabolism 15. patients considered inadequate for inclusion in this trial by the physician
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Frequency or severity of oral erosion
- Secondary Outcome Measures
Name Time Method 1.Frequency of diarrhea, nausea or vomitting 2.Frequency of comlpetion of chemoradiotherapy of chemotherapy 3.decrease of Nutrition marker 4.loss of body weight 5.intake of Elental